Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||ATLCAR.CD30 cells|
|Synonyms||CAR.CD30 T cells|ATLCAR.CD30-CD28zeta cells|SFG.CAR.CD30 ATL|
ATLCAR.CD30 cells are autologous T-lymphocytes engineered to express a chimeric antigen receptor that targets CD30, potentially leading to immune response against CD30-positive tumor cells (PMID: 30841880).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|ATLCAR.CD30 cells||ATLCAR.CD30 cells||0||4|
|ATLCAR.CD30 cells + ATLCAR.CD30.CCR4 cells||ATLCAR.CD30 cells ATLCAR.CD30.CCR4 cells||0||1|
|ATLCAR.CD30 cells + Cyclophosphamide + Fludarabine||ATLCAR.CD30 cells Cyclophosphamide Fludarabine||0||1|